Boothbay Fund Management, LLC Wave Life Sciences Ltd. Transaction History
Boothbay Fund Management, LLC
- $3.27 Billion
- Q4 2024
A detailed history of Boothbay Fund Management, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 29,400 shares of WVE stock, worth $298,998. This represents 0.01% of its overall portfolio holdings.
Number of Shares
29,400
Previous 174,112
83.11%
Holding current value
$298,998
Previous $1.43 Million
74.56%
% of portfolio
0.01%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding WVE
# of Institutions
192Shares Held
122MCall Options Held
430KPut Options Held
330K-
Ra Capital Management, L.P. Boston, MA18.2MShares$185 Million3.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.62MShares$97.9 Million0.22% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$84 Million1.98% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$68.5 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.71MShares$68.3 Million0.81% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $883M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...